PITTSBURGH, Feb. 20 /PRNewswire/ -- Applied Isotope Technologies
("AIT") announced today, that the EPA Method 6800 has been published in
January 2008 edition of the Federal Register as a part of the methods
section of a broad set of US environmental statutes known as RCRA (Resource
Conservation and Recovery Act). This updated version of the method includes
a long list of samples and data, including soil, water, tissue, yeast,
hair, industrial material, etc. AIT sells products that support Method
6800.

Matt Pamuku, CEO and President of AIT said, "Method 6800 now joins a
group of critical testing methods for the US and the world to follow, so
that we can help protect our environment and health of its inhabitants.
This powerful method is one of the most accurate and fail-proof tests that
has ever been invented." Mr. Pamuku continued, "As a singular source of
products, AIT is proud to have supported Method 6800 in the past, as it
went through ten years of scientific scrutiny as a draft EPA method."

The EPA RCRA Method 6800 provides a powerful method that incorporates
an advanced version of the venerable isotope dilution technique, accepted
as one of the most reliable analytical tools in the analytical chemistry
field. The unique approach detailed in the Method 6800 provides the
ability, for the first time, to obtain results that can withstand legal
challenge in the courts. This is a critical and much valued attribute for
many regulatory agencies, such as the Environmental Protection Agency,
Centers for Disease Control and Federal Drug Administration, and
communities affected by industrial pollution.

In addition to legal defensibility, the Method 6800 is also uniquely
helpful in identifying sources of errors in other methods. Over the past
decade, a number of peer-reviewed publications have utilized this method to
better understand and optimize the performance of other analytical
techniques. Mr. Pamuku commented, "The analysts who adopted the Method 6800
are always delighted that such performance can be achieved without
calibration curves which require long, frequent, and often expensive and
frustrating work."

AIT develops and sells Method 6800 compliant products that can be used
in a special class of instruments called mass spectrometers that are widely
used in almost every analytical laboratory involved in environment-related
analytical work. AIT's mercury products, for example, helps accurately
identify and measure highly toxic mercury species, such as methylmercury
that can be found in some of the popular food sources, such as fish, as a
consequence of industrial pollution. AIT products facilitate detection at
less than 10 parts per trillion levels without compromising accuracy which
is particularly an important consideration for supertoxin analysis.
http://www.SIDMS.com

(Date:12/8/2016)... , December 8, 2016 ... expanded its customisable SureSeq™ NGS panel range with the launch ... fast and cost-effective study of variants in familial hypercholesterolemia (FH). ... variation (CNV) detection on a single small panel and allows ... content. This includes all exons for LDLR , ...

(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review ... biotech crops. The authors focus on the economic effects in countries that are major ... new biotech crops and the resultant risk of low level presence (LLP) puts large ...

(Date:12/7/2016)... 7, 2016 Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...

(Date:12/5/2016)... Dec. 5, 2016 The Office of Justice ... "Can CT Scans Enhance or Replace Medico Legal ... of supporting or replacing forensic autopsies with postmortem ... In response to recommendations made by ... using CT scans as a potential component of ...

(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...